Nentwig J, Grünewald K, Vollmer B (2026). When structural rationales fall short: revisiting the immunogenicity of herpesvirus prefusion and postfusion glycoprotein B.
Curr Opin Virol. 76/2026;
PubMed
Vollmer B, Ebel H, Rees R, Nentwig J, Mulvaney T, Schünemann J, Krull J, Topf M, Görlich D, Grünewald K (2025). A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2.
Nature. 2025 Sep 03;
PubMed
